Morning Break: Pricey Drugs Spur Protest, the Price for Long Life

Health news and commentary from around the Web, gathered by the MedPage Today staff

Infectious disease specialists are crying foul about Turing Pharmaceuticals' decision to hike the price of the toxoplasmosis treatment drug Daraprim from $13.50 to $760 per tablet -- the latest in a series of price hikes following acquisitions. (The New York Times)

The New York Times says cardiologist Robert Califf's well-known industry ties have some people raising questions about the wisdom of appointing him as FDA commissioner. Here's what experts told MedPage Today.

Community health centers in California say financial obstacles including complicated billing requirements make it difficult for them use telemedicine consults, writes David Raths in Healthcare Informatics.

Turns out that appeal of fast food is income-agnostic: the CDC says that Ronald McDonald welcomes the rich, the poor, and the middle-class and by the numbers about 11.5% of calories consumed by poor kids comes from fast food versus 13% of calories consumed by all other kids.

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.